Jonathan Wolleben
Stock Analyst at JMP Securities
(1.44)
# 1455
Out of 5,327 analysts
204
Total ratings
41.24%
Success rate
7.27%
Average return
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
MDGL Madrigal Pharmaceuti... | Reiterates: Market Outperform | 443 443 | 326.66 | 35.62% | 12 | Apr 24, 2025 | |
MBX MBX Biosciences | Initiates Coverage On: Market Outperform | 38 | 9.15 | 315.3% | 1 | Apr 10, 2025 | |
ALT Altimmune | Reiterates: Market Outperform | 25 25 | 5.08 | 392.13% | 12 | Apr 2, 2025 | |
CLSD Clearside Biomedical | Reiterates: Market Outperform | 5 5 | 0.84 | 495.24% | 10 | Mar 28, 2025 | |
KALV KalVista Pharma | Reiterates: Market Outperform | 19 19 | n/a | n/a | 3 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Outperform | 21 19 | 5.4 | 251.85% | 7 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Market Outperform | 15 15 | n/a | n/a | 2 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Market Outperform | 61 61 | 44.48 | 37.14% | 11 | Mar 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Outperform | 22 19 | 7.71 | 146.43% | 17 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Market Outperform | 10 10 | 8.58 | 16.55% | 13 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Market Outperform | 55 55 | 16.79 | 227.58% | 11 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Market Outperform | 18 18 | 8.39 | 114.54% | 7 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Market Outperform | 26 26 | 5.17 | 402.9% | 2 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Outperform | 91 87 | 23.84 | 264.93% | 8 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Outperform | 92 91 | 32.42 | 180.69% | 14 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Market Outperform | 74 74 | 40.82 | 81.28% | 9 | Feb 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Market Outperform | 75 75 | 63.86 | 17.44% | 2 | Dec 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Market Outperform | 9 9 | 3.19 | 182.13% | 8 | Dec 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Outperform | 55 50 | 34.45 | 45.14% | 1 | Dec 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Market Outperform | 90 90 | 82.85 | 8.63% | 1 | Dec 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Market Perform | n/a | n/a | n/a | 1 | Dec 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Market Outperform | 8 8 | 1.43 | 459.44% | 6 | Dec 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 3 3 | 0.13 | 2207.69% | 7 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Accumulate | 420 485 | 620.08 | -21.78% | 1 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Market Outperform | 3 3 | 0.33 | 809.09% | 6 | Sep 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Outperform | 48 32 | 3.15 | 915.87% | 8 | Aug 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Market Outperform | 25 25 | 2.33 | 972.96% | 11 | May 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Market Outperform | 8 8 | 0.31 | 2480.65% | 11 | Apr 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 25 24 | n/a | n/a | 1 | May 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | n/a | n/a | n/a | 1 | May 25, 2021 |